These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 19348861)

  • 41. Inherited Epigenetic Hallmarks of Childhood Obesity Derived from Prenatal Exposure to Obesogens.
    Núñez-Sánchez MÁ; Jiménez-Méndez A; Suárez-Cortés M; Martínez-Sánchez MA; Sánchez-Solís M; Blanco-Carnero JE; Ruiz-Alcaraz AJ; Ramos-Molina B
    Int J Environ Res Public Health; 2023 Mar; 20(6):. PubMed ID: 36981620
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The new kids on the block: Emerging obesogens.
    Chamorro-Garcia R; Veiga-Lopez A
    Adv Pharmacol; 2021; 92():457-484. PubMed ID: 34452694
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Perturbation of Nuclear Hormone Receptors by Endocrine Disrupting Chemicals: Mechanisms and Pathological Consequences of Exposure.
    Hall JM; Greco CW
    Cells; 2019 Dec; 9(1):. PubMed ID: 31861598
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current Research Approaches and Challenges in the Obesogen Field.
    Chamorro-Garcia R; Blumberg B
    Front Endocrinol (Lausanne); 2019; 10():167. PubMed ID: 30967838
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polluted Pathways: Mechanisms of Metabolic Disruption by Endocrine Disrupting Chemicals.
    Mimoto MS; Nadal A; Sargis RM
    Curr Environ Health Rep; 2017 Jun; 4(2):208-222. PubMed ID: 28432637
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Environmental signaling: from environmental estrogens to endocrine-disrupting chemicals and beyond.
    McLachlan JA
    Andrology; 2016 Jul; 4(4):684-94. PubMed ID: 27230799
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endocrine disrupting chemicals and growth of children.
    Botton J; Kadawathagedara M; de Lauzon-Guillain B
    Ann Endocrinol (Paris); 2017 Jun; 78(2):108-111. PubMed ID: 28483365
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Endocrine disruptors and obesity: obesogens].
    García-Mayor RV; Larrañaga Vidal A; Docet Caamaño MF; Lafuente Giménez A
    Endocrinol Nutr; 2012 Apr; 59(4):261-7. PubMed ID: 22300604
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transgenerational effects of obesogens and the obesity epidemic.
    Chamorro-García R; Blumberg B
    Curr Opin Pharmacol; 2014 Dec; 19():153-8. PubMed ID: 25460228
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Putative environmental-endocrine disruptors and obesity: a review.
    Elobeid MA; Allison DB
    Curr Opin Endocrinol Diabetes Obes; 2008 Oct; 15(5):403-8. PubMed ID: 18769210
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adipocytes under assault: environmental disruption of adipose physiology.
    Regnier SM; Sargis RM
    Biochim Biophys Acta; 2014 Mar; 1842(3):520-33. PubMed ID: 23735214
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The utility of vitellogenin as a biomarker of estrogenic endocrine disrupting chemicals in molluscs.
    Tran TKA; Yu RMK; Islam R; Nguyen THT; Bui TLH; Kong RYC; O'Connor WA; Leusch FDL; Andrew-Priestley M; MacFarlane GR
    Environ Pollut; 2019 May; 248():1067-1078. PubMed ID: 31091639
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The relationship of obesity with lifestyle and dietary exposure to endocrine-disrupting chemicals.
    Heras-González L; Latorre JA; Martinez-Bebia M; Espino D; Olea-Serrano F; Mariscal-Arcas M
    Food Chem Toxicol; 2020 Feb; 136():110983. PubMed ID: 31759064
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endocrine disrupting chemicals: exposure, effects on human health, mechanism of action, models for testing and strategies for prevention.
    Yilmaz B; Terekeci H; Sandal S; Kelestimur F
    Rev Endocr Metab Disord; 2020 Mar; 21(1):127-147. PubMed ID: 31792807
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prenatal Exposure to Endocrine Disruptors and Reprogramming of Adipogenesis: An Early-Life Risk Factor for Childhood Obesity.
    Shafei AE; Nabih ES; Shehata KA; Abd Elfatah ESM; Sanad ABA; Marey MY; Hammouda AAMA; Mohammed MMM; Mostafa R; Ali MA
    Child Obes; 2018 Jan; 14(1):18-25. PubMed ID: 29019419
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endocrine-disrupting compounds and metabolomic reprogramming in breast cancer.
    Winz C; Zong WX; Suh N
    J Biochem Mol Toxicol; 2023 Dec; 37(12):e23506. PubMed ID: 37598318
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is exposure to environmental or industrial endocrine disrupting estrogen-like chemicals able to cause genomic instability?
    Roy D; Colerangle JB; Singh KP
    Front Biosci; 1998 Aug; 3():d913-21. PubMed ID: 9696883
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Obesogens in the aquatic environment: an evolutionary and toxicological perspective.
    Capitão A; Lyssimachou A; Castro LFC; Santos MM
    Environ Int; 2017 Sep; 106():153-169. PubMed ID: 28662399
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Roles of estrogens, estrogen-like compounds, and endocrine disruptors in adipocytes.
    Lizcano F
    Front Endocrinol (Lausanne); 2022; 13():921504. PubMed ID: 36213285
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In silico methods in the discovery of endocrine disrupting chemicals.
    Vuorinen A; Odermatt A; Schuster D
    J Steroid Biochem Mol Biol; 2013 Sep; 137():18-26. PubMed ID: 23688835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.